This is a working overview of Anti-doping testing, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-24. Anything still debated is marked as such rather than presented as settled.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
When danger loomed, all the burgers (citizens) in a district would form a military unit called a commando and elect officers. A full-time official called a Veldkornet maintained muster rolls but had no disciplinary powers. Each man brought his own weapon, usually a hunting rifle, and horse. Those who could not afford a gun were given one by the authorities. The presidents of the Transvaal and Orange Free State simply signed decrees to concentrate within a week, and the commandos could muster between 30,000-40,000 men. Many did not look forward to fighting against fellow Christians and, by and large, fellow Protestants. Many had an overly optimistic sense of what the war would involve, imagining victory could be achieved as fast and easily as in the First Anglo-Boer War. Many, including many generals, had a sense their cause was holy and just, and blessed by God. It rapidly became clear that the Boers presented the British forces with a severe tactical challenge. The Boers presented a mobile and innovative approach to warfare, drawing on their experiences from the First Boer War. The Boers who made up their commandos were farmers who had their working life in the saddle, as farmers and hunters. They depended on the pot, horse and rifle; they were skilled stalkers and marksmen. As hunters, they had learned to fire from cover; from a prone position and to make the first shot count, knowing that if they missed, the game would be long gone or could charge and potentially kill them.
==== Absorption ==== The total absorption of ramelteon is 84% while its oral bioavailability is 1.8%. The low bioavailability of ramelteon is due to extensive first-pass metabolism. Ramelteon has a higher lipophilicity than melatonin and thus permeates more easily into tissue. The absorption of ramelteon is rapid, with peak levels being reached after approximately 0.75 hours (range 0.5–1.5 hours). Food increases peak concentrations of ramelteon by 22% and overall exposure by 31% and delays the time to peak levels by approximately 0.75 hours. The pharmacokinetics of ramelteon are linear across a dose range of 4 to 64 mg. There is substantial interindividual variability in the peak concentrations and area-under-the-curve levels of ramelteon which is consistent with high first-pass metabolism.
Noni tea Oksusu cha, traditional roasted corn tea found in Korea Olive leaf tea Oregano tea Osmanthus tea, dried flowers of the sweet olive tree, are used alone or blended with tea leaves in China. Pandan tea Patchouli tea Pennyroyal leaf, an abortifacient Pine needle tea, or tallstrunt, made from needles of pine trees Qishr, Yemeni drink with coffee husks and ginger Red clover tea Red raspberry leaf Rosa × damascena tea, in the Middle East. Roasted wheat, used in Postum, a coffee substitute Rooibos (red bush), a reddish plant used to make an infusion and grown in South Africa. In the US it is sometimes called red tea. It has many of the antioxidant characteristics of green tea, but because it does not come from tea leaves, it has no caffeine. Rose hip (often blended with hibiscus) Roselle petals (species of hibiscus; known by other names including bissau and dah), consumed in the Sahel and elsewhere Rosemary Sabah snake grass is used as a traditional herbal tea infusion in Southeast Asia. Sagebrush, California sagebrush Sage Sakurayu, Japanese herbal tea made with pickled cherry blossom petals Sassafras roots were steeped to make tea, a practice which was common among Native Americans. They were also used in the flavoring of root beer until being banned by the FDA.
Sources: en.wikipedia.org
==== United Nations Climate Change Conference ==== On 1 November 2022, the COP27 host Egypt invited then President-elect Lula to visit the summit which raised hopes among climate activists and international organizations officials that Brazil will strengthen its environmental policies. Lula accepted the invitation and, while attending the COP27, promised to fight for a zero deforestation in the Amazon and other biomes. He also promised to have a United Nations Climate Change conference held in the Amazon. On 11 January 2023, Lula announced Brazil was making an official bid for the Brazilian city of Belém to host the COP 30. In May 2023, the UN announced that Belém had been chosen to host the summit, a first for a city in the Amazon region. During the COP28, Lula announced that Brazil would join the OPEC+ initiative, which focuses on integration and discussion between members of the group and other countries. He also announced a plan to recover degraded pasturelands, and to boost overall agriculture productivity through loans by Brazil's BNDES.
== Ligands == Several selective ligands for the oxytocin receptor have been developed, but close similarity between the oxytocin and related vasopressin receptors make it difficult to achieve high selectivity with peptide derivatives. However the search for a druggable, non-peptide template has led to several potent, highly selective, orally bioavailable oxytocin receptor antagonists. Oxytocin receptor agonists have also been developed.
==== Elimination ==== Muscimol is excreted by the kidneys into urine. It is excreted partially unmetabolized. This has been taken advantage of by Siberian practitioners of the traditional entheogenic use of Amanita muscaria via recycling of muscimol in urine. The elimination half-life of muscimol in humans is unknown. The closely related drug gaboxadol (THIP), which is a cyclized derivative of muscimol, has an elimination half-life in humans of 1.5 to 2 hours. In rodents, the half-life of gaboxadol was about twice as long as that of muscimol. Gaboxadol is said to be more resistant to metabolism than muscimol, for instance not being a substrate for GABA-T. Despite the preceding findings however, gaboxadol is shorter-lasting in its effects than muscimol in rats, with durations of up to 3 hours and more than 5 hours, respectively.
=== 3 April === Polish presidential aide Marcin Przydacz stated that Poland transferred some MiG-29 fighter jets to Ukraine. Poland had pledged to deliver 4 jets in the first batch. Secretary General of NATO, Jens Stoltenberg, announced that Finland was set to join NATO on 4 April. Stoltenberg also stated that he was confident that Sweden will also join NATO in the near future.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.